Global Contraceptive Transdermal Patche Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Medical Vacuum Regulator market size is predicted to grow from US$ 166 million in 2025 to US$ 235 million in 2031; it is expected to grow at a CAGR of 6.0% from 2025 to 2031.
Medical Vacuum Regulator is a medical device that converts the high-pressure vacuum that is supplied by the hospitals central vacuum system to a safe level for use on a patient.
The vacuum regulator is used to measure and adjust the vacuum level within the context of medical suction. It enables to drain substances out of the patient’s body during surgical procedures. The vacuum regulator should be connected to a vacuum source on the wall either using a direct probe or a rail mounting system. It should be associated with a collection jar and a suction hose.
Global Medical Vacuum Regulator key players include Ohio Medical, Amico, Precision Medical, Air Liquid Healthcare, Integral, etc. Global top five manufacturers hold a share about 35%.
North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, having a total share about 55 percent.
In terms of product, Analog Vacuum Regulator is the largest segment, with a share about 70%. And in terms of application, the largest application is in Clinical, followed by Surgical.
LP Information, Inc. (LPI) ' newest research report, the “Medical Vacuum Regulator Industry Forecast” looks at past sales and reviews total world Medical Vacuum Regulator sales in 2024, providing a comprehensive analysis by region and market sector of projected Medical Vacuum Regulator sales for 2025 through 2031. With Medical Vacuum Regulator sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Vacuum Regulator industry.
This Insight Report provides a comprehensive analysis of the global Medical Vacuum Regulator landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Vacuum Regulator portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Vacuum Regulator market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Vacuum Regulator and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Vacuum Regulator.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Vacuum Regulator market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Medical Vacuum Regulator market?
What factors are driving Medical Vacuum Regulator market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Medical Vacuum Regulator market opportunities vary by end market size?
How does Medical Vacuum Regulator break out by Type, by Application?
The global Medical Vacuum Regulator market size is predicted to grow from US$ 166 million in 2025 to US$ 235 million in 2031; it is expected to grow at a CAGR of 6.0% from 2025 to 2031.
Medical Vacuum Regulator is a medical device that converts the high-pressure vacuum that is supplied by the hospitals central vacuum system to a safe level for use on a patient.
The vacuum regulator is used to measure and adjust the vacuum level within the context of medical suction. It enables to drain substances out of the patient’s body during surgical procedures. The vacuum regulator should be connected to a vacuum source on the wall either using a direct probe or a rail mounting system. It should be associated with a collection jar and a suction hose.
Global Medical Vacuum Regulator key players include Ohio Medical, Amico, Precision Medical, Air Liquid Healthcare, Integral, etc. Global top five manufacturers hold a share about 35%.
North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, having a total share about 55 percent.
In terms of product, Analog Vacuum Regulator is the largest segment, with a share about 70%. And in terms of application, the largest application is in Clinical, followed by Surgical.
LP Information, Inc. (LPI) ' newest research report, the “Medical Vacuum Regulator Industry Forecast” looks at past sales and reviews total world Medical Vacuum Regulator sales in 2024, providing a comprehensive analysis by region and market sector of projected Medical Vacuum Regulator sales for 2025 through 2031. With Medical Vacuum Regulator sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Vacuum Regulator industry.
This Insight Report provides a comprehensive analysis of the global Medical Vacuum Regulator landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Vacuum Regulator portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Vacuum Regulator market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Vacuum Regulator and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Vacuum Regulator.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Vacuum Regulator market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Analog Vacuum Regulator
- Digital Vacuum Regulator
- Clinically
- Surgical
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Ohio Medical
- Amico
- Precision Medical
- Air Liquid Healthcare
- Integral
- Allied Healthcare Products
- Shanghai Amcaremed Technology
- Acare
- Hersill
What is the 10-year outlook for the global Medical Vacuum Regulator market?
What factors are driving Medical Vacuum Regulator market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Medical Vacuum Regulator market opportunities vary by end market size?
How does Medical Vacuum Regulator break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Contraceptive Transdermal Patche Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Contraceptive Transdermal Patche by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Contraceptive Transdermal Patche by Country/Region, 2020, 2024 & 2031
2.2 Contraceptive Transdermal Patche Segment by Type
2.2.1 Progestin-only Contraceptive
2.2.2 Combined Hormonal Contraceptive
2.3 Contraceptive Transdermal Patche Sales by Type
2.3.1 Global Contraceptive Transdermal Patche Sales Market Share by Type (2020-2025)
2.3.2 Global Contraceptive Transdermal Patche Revenue and Market Share by Type (2020-2025)
2.3.3 Global Contraceptive Transdermal Patche Sale Price by Type (2020-2025)
2.4 Contraceptive Transdermal Patche Segment by Application
2.4.1 Hospitals
2.4.2 Household
2.4.3 Clinics
2.5 Contraceptive Transdermal Patche Sales by Application
2.5.1 Global Contraceptive Transdermal Patche Sale Market Share by Application (2020-2025)
2.5.2 Global Contraceptive Transdermal Patche Revenue and Market Share by Application (2020-2025)
2.5.3 Global Contraceptive Transdermal Patche Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Contraceptive Transdermal Patche Breakdown Data by Company
3.1.1 Global Contraceptive Transdermal Patche Annual Sales by Company (2020-2025)
3.1.2 Global Contraceptive Transdermal Patche Sales Market Share by Company (2020-2025)
3.2 Global Contraceptive Transdermal Patche Annual Revenue by Company (2020-2025)
3.2.1 Global Contraceptive Transdermal Patche Revenue by Company (2020-2025)
3.2.2 Global Contraceptive Transdermal Patche Revenue Market Share by Company (2020-2025)
3.3 Global Contraceptive Transdermal Patche Sale Price by Company
3.4 Key Manufacturers Contraceptive Transdermal Patche Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Contraceptive Transdermal Patche Product Location Distribution
3.4.2 Players Contraceptive Transdermal Patche Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CONTRACEPTIVE TRANSDERMAL PATCHE BY GEOGRAPHIC REGION
4.1 World Historic Contraceptive Transdermal Patche Market Size by Geographic Region (2020-2025)
4.1.1 Global Contraceptive Transdermal Patche Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Contraceptive Transdermal Patche Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Contraceptive Transdermal Patche Market Size by Country/Region (2020-2025)
4.2.1 Global Contraceptive Transdermal Patche Annual Sales by Country/Region (2020-2025)
4.2.2 Global Contraceptive Transdermal Patche Annual Revenue by Country/Region (2020-2025)
4.3 Americas Contraceptive Transdermal Patche Sales Growth
4.4 APAC Contraceptive Transdermal Patche Sales Growth
4.5 Europe Contraceptive Transdermal Patche Sales Growth
4.6 Middle East & Africa Contraceptive Transdermal Patche Sales Growth
5 AMERICAS
5.1 Americas Contraceptive Transdermal Patche Sales by Country
5.1.1 Americas Contraceptive Transdermal Patche Sales by Country (2020-2025)
5.1.2 Americas Contraceptive Transdermal Patche Revenue by Country (2020-2025)
5.2 Americas Contraceptive Transdermal Patche Sales by Type (2020-2025)
5.3 Americas Contraceptive Transdermal Patche Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Contraceptive Transdermal Patche Sales by Region
6.1.1 APAC Contraceptive Transdermal Patche Sales by Region (2020-2025)
6.1.2 APAC Contraceptive Transdermal Patche Revenue by Region (2020-2025)
6.2 APAC Contraceptive Transdermal Patche Sales by Type (2020-2025)
6.3 APAC Contraceptive Transdermal Patche Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Contraceptive Transdermal Patche by Country
7.1.1 Europe Contraceptive Transdermal Patche Sales by Country (2020-2025)
7.1.2 Europe Contraceptive Transdermal Patche Revenue by Country (2020-2025)
7.2 Europe Contraceptive Transdermal Patche Sales by Type (2020-2025)
7.3 Europe Contraceptive Transdermal Patche Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Contraceptive Transdermal Patche by Country
8.1.1 Middle East & Africa Contraceptive Transdermal Patche Sales by Country (2020-2025)
8.1.2 Middle East & Africa Contraceptive Transdermal Patche Revenue by Country (2020-2025)
8.2 Middle East & Africa Contraceptive Transdermal Patche Sales by Type (2020-2025)
8.3 Middle East & Africa Contraceptive Transdermal Patche Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Contraceptive Transdermal Patche
10.3 Manufacturing Process Analysis of Contraceptive Transdermal Patche
10.4 Industry Chain Structure of Contraceptive Transdermal Patche
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Contraceptive Transdermal Patche Distributors
11.3 Contraceptive Transdermal Patche Customer
12 WORLD FORECAST REVIEW FOR CONTRACEPTIVE TRANSDERMAL PATCHE BY GEOGRAPHIC REGION
12.1 Global Contraceptive Transdermal Patche Market Size Forecast by Region
12.1.1 Global Contraceptive Transdermal Patche Forecast by Region (2026-2031)
12.1.2 Global Contraceptive Transdermal Patche Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Contraceptive Transdermal Patche Forecast by Type (2026-2031)
12.7 Global Contraceptive Transdermal Patche Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Mylan Nv
13.1.1 Mylan Nv Company Information
13.1.2 Mylan Nv Contraceptive Transdermal Patche Product Portfolios and Specifications
13.1.3 Mylan Nv Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Mylan Nv Main Business Overview
13.1.5 Mylan Nv Latest Developments
13.2 Ansell Limited
13.2.1 Ansell Limited Company Information
13.2.2 Ansell Limited Contraceptive Transdermal Patche Product Portfolios and Specifications
13.2.3 Ansell Limited Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Ansell Limited Main Business Overview
13.2.5 Ansell Limited Latest Developments
13.3 Bayer AG
13.3.1 Bayer AG Company Information
13.3.2 Bayer AG Contraceptive Transdermal Patche Product Portfolios and Specifications
13.3.3 Bayer AG Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bayer AG Main Business Overview
13.3.5 Bayer AG Latest Developments
13.4 Church & Dwight Co., Inc.
13.4.1 Church & Dwight Co., Inc. Company Information
13.4.2 Church & Dwight Co., Inc. Contraceptive Transdermal Patche Product Portfolios and Specifications
13.4.3 Church & Dwight Co., Inc. Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Church & Dwight Co., Inc. Main Business Overview
13.4.5 Church & Dwight Co., Inc. Latest Developments
13.5 Merck & Co., Inc.
13.5.1 Merck & Co., Inc. Company Information
13.5.2 Merck & Co., Inc. Contraceptive Transdermal Patche Product Portfolios and Specifications
13.5.3 Merck & Co., Inc. Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Merck & Co., Inc. Main Business Overview
13.5.5 Merck & Co., Inc. Latest Developments
13.6 Pfizer Inc.
13.6.1 Pfizer Inc. Company Information
13.6.2 Pfizer Inc. Contraceptive Transdermal Patche Product Portfolios and Specifications
13.6.3 Pfizer Inc. Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Pfizer Inc. Main Business Overview
13.6.5 Pfizer Inc. Latest Developments
13.7 Teva Pharmaceutical Industries Limited
13.7.1 Teva Pharmaceutical Industries Limited Company Information
13.7.2 Teva Pharmaceutical Industries Limited Contraceptive Transdermal Patche Product Portfolios and Specifications
13.7.3 Teva Pharmaceutical Industries Limited Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Teva Pharmaceutical Industries Limited Main Business Overview
13.7.5 Teva Pharmaceutical Industries Limited Latest Developments
13.8 The Cooper Companies, Inc.
13.8.1 The Cooper Companies, Inc. Company Information
13.8.2 The Cooper Companies, Inc. Contraceptive Transdermal Patche Product Portfolios and Specifications
13.8.3 The Cooper Companies, Inc. Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 The Cooper Companies, Inc. Main Business Overview
13.8.5 The Cooper Companies, Inc. Latest Developments
13.9 The Female Health Company
13.9.1 The Female Health Company Company Information
13.9.2 The Female Health Company Contraceptive Transdermal Patche Product Portfolios and Specifications
13.9.3 The Female Health Company Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 The Female Health Company Main Business Overview
13.9.5 The Female Health Company Latest Developments
13.10 Abviee Inc
13.10.1 Abviee Inc Company Information
13.10.2 Abviee Inc Contraceptive Transdermal Patche Product Portfolios and Specifications
13.10.3 Abviee Inc Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Abviee Inc Main Business Overview
13.10.5 Abviee Inc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Contraceptive Transdermal Patche Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Contraceptive Transdermal Patche by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Contraceptive Transdermal Patche by Country/Region, 2020, 2024 & 2031
2.2 Contraceptive Transdermal Patche Segment by Type
2.2.1 Progestin-only Contraceptive
2.2.2 Combined Hormonal Contraceptive
2.3 Contraceptive Transdermal Patche Sales by Type
2.3.1 Global Contraceptive Transdermal Patche Sales Market Share by Type (2020-2025)
2.3.2 Global Contraceptive Transdermal Patche Revenue and Market Share by Type (2020-2025)
2.3.3 Global Contraceptive Transdermal Patche Sale Price by Type (2020-2025)
2.4 Contraceptive Transdermal Patche Segment by Application
2.4.1 Hospitals
2.4.2 Household
2.4.3 Clinics
2.5 Contraceptive Transdermal Patche Sales by Application
2.5.1 Global Contraceptive Transdermal Patche Sale Market Share by Application (2020-2025)
2.5.2 Global Contraceptive Transdermal Patche Revenue and Market Share by Application (2020-2025)
2.5.3 Global Contraceptive Transdermal Patche Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Contraceptive Transdermal Patche Breakdown Data by Company
3.1.1 Global Contraceptive Transdermal Patche Annual Sales by Company (2020-2025)
3.1.2 Global Contraceptive Transdermal Patche Sales Market Share by Company (2020-2025)
3.2 Global Contraceptive Transdermal Patche Annual Revenue by Company (2020-2025)
3.2.1 Global Contraceptive Transdermal Patche Revenue by Company (2020-2025)
3.2.2 Global Contraceptive Transdermal Patche Revenue Market Share by Company (2020-2025)
3.3 Global Contraceptive Transdermal Patche Sale Price by Company
3.4 Key Manufacturers Contraceptive Transdermal Patche Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Contraceptive Transdermal Patche Product Location Distribution
3.4.2 Players Contraceptive Transdermal Patche Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CONTRACEPTIVE TRANSDERMAL PATCHE BY GEOGRAPHIC REGION
4.1 World Historic Contraceptive Transdermal Patche Market Size by Geographic Region (2020-2025)
4.1.1 Global Contraceptive Transdermal Patche Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Contraceptive Transdermal Patche Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Contraceptive Transdermal Patche Market Size by Country/Region (2020-2025)
4.2.1 Global Contraceptive Transdermal Patche Annual Sales by Country/Region (2020-2025)
4.2.2 Global Contraceptive Transdermal Patche Annual Revenue by Country/Region (2020-2025)
4.3 Americas Contraceptive Transdermal Patche Sales Growth
4.4 APAC Contraceptive Transdermal Patche Sales Growth
4.5 Europe Contraceptive Transdermal Patche Sales Growth
4.6 Middle East & Africa Contraceptive Transdermal Patche Sales Growth
5 AMERICAS
5.1 Americas Contraceptive Transdermal Patche Sales by Country
5.1.1 Americas Contraceptive Transdermal Patche Sales by Country (2020-2025)
5.1.2 Americas Contraceptive Transdermal Patche Revenue by Country (2020-2025)
5.2 Americas Contraceptive Transdermal Patche Sales by Type (2020-2025)
5.3 Americas Contraceptive Transdermal Patche Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Contraceptive Transdermal Patche Sales by Region
6.1.1 APAC Contraceptive Transdermal Patche Sales by Region (2020-2025)
6.1.2 APAC Contraceptive Transdermal Patche Revenue by Region (2020-2025)
6.2 APAC Contraceptive Transdermal Patche Sales by Type (2020-2025)
6.3 APAC Contraceptive Transdermal Patche Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Contraceptive Transdermal Patche by Country
7.1.1 Europe Contraceptive Transdermal Patche Sales by Country (2020-2025)
7.1.2 Europe Contraceptive Transdermal Patche Revenue by Country (2020-2025)
7.2 Europe Contraceptive Transdermal Patche Sales by Type (2020-2025)
7.3 Europe Contraceptive Transdermal Patche Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Contraceptive Transdermal Patche by Country
8.1.1 Middle East & Africa Contraceptive Transdermal Patche Sales by Country (2020-2025)
8.1.2 Middle East & Africa Contraceptive Transdermal Patche Revenue by Country (2020-2025)
8.2 Middle East & Africa Contraceptive Transdermal Patche Sales by Type (2020-2025)
8.3 Middle East & Africa Contraceptive Transdermal Patche Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Contraceptive Transdermal Patche
10.3 Manufacturing Process Analysis of Contraceptive Transdermal Patche
10.4 Industry Chain Structure of Contraceptive Transdermal Patche
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Contraceptive Transdermal Patche Distributors
11.3 Contraceptive Transdermal Patche Customer
12 WORLD FORECAST REVIEW FOR CONTRACEPTIVE TRANSDERMAL PATCHE BY GEOGRAPHIC REGION
12.1 Global Contraceptive Transdermal Patche Market Size Forecast by Region
12.1.1 Global Contraceptive Transdermal Patche Forecast by Region (2026-2031)
12.1.2 Global Contraceptive Transdermal Patche Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Contraceptive Transdermal Patche Forecast by Type (2026-2031)
12.7 Global Contraceptive Transdermal Patche Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Mylan Nv
13.1.1 Mylan Nv Company Information
13.1.2 Mylan Nv Contraceptive Transdermal Patche Product Portfolios and Specifications
13.1.3 Mylan Nv Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Mylan Nv Main Business Overview
13.1.5 Mylan Nv Latest Developments
13.2 Ansell Limited
13.2.1 Ansell Limited Company Information
13.2.2 Ansell Limited Contraceptive Transdermal Patche Product Portfolios and Specifications
13.2.3 Ansell Limited Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Ansell Limited Main Business Overview
13.2.5 Ansell Limited Latest Developments
13.3 Bayer AG
13.3.1 Bayer AG Company Information
13.3.2 Bayer AG Contraceptive Transdermal Patche Product Portfolios and Specifications
13.3.3 Bayer AG Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bayer AG Main Business Overview
13.3.5 Bayer AG Latest Developments
13.4 Church & Dwight Co., Inc.
13.4.1 Church & Dwight Co., Inc. Company Information
13.4.2 Church & Dwight Co., Inc. Contraceptive Transdermal Patche Product Portfolios and Specifications
13.4.3 Church & Dwight Co., Inc. Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Church & Dwight Co., Inc. Main Business Overview
13.4.5 Church & Dwight Co., Inc. Latest Developments
13.5 Merck & Co., Inc.
13.5.1 Merck & Co., Inc. Company Information
13.5.2 Merck & Co., Inc. Contraceptive Transdermal Patche Product Portfolios and Specifications
13.5.3 Merck & Co., Inc. Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Merck & Co., Inc. Main Business Overview
13.5.5 Merck & Co., Inc. Latest Developments
13.6 Pfizer Inc.
13.6.1 Pfizer Inc. Company Information
13.6.2 Pfizer Inc. Contraceptive Transdermal Patche Product Portfolios and Specifications
13.6.3 Pfizer Inc. Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Pfizer Inc. Main Business Overview
13.6.5 Pfizer Inc. Latest Developments
13.7 Teva Pharmaceutical Industries Limited
13.7.1 Teva Pharmaceutical Industries Limited Company Information
13.7.2 Teva Pharmaceutical Industries Limited Contraceptive Transdermal Patche Product Portfolios and Specifications
13.7.3 Teva Pharmaceutical Industries Limited Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Teva Pharmaceutical Industries Limited Main Business Overview
13.7.5 Teva Pharmaceutical Industries Limited Latest Developments
13.8 The Cooper Companies, Inc.
13.8.1 The Cooper Companies, Inc. Company Information
13.8.2 The Cooper Companies, Inc. Contraceptive Transdermal Patche Product Portfolios and Specifications
13.8.3 The Cooper Companies, Inc. Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 The Cooper Companies, Inc. Main Business Overview
13.8.5 The Cooper Companies, Inc. Latest Developments
13.9 The Female Health Company
13.9.1 The Female Health Company Company Information
13.9.2 The Female Health Company Contraceptive Transdermal Patche Product Portfolios and Specifications
13.9.3 The Female Health Company Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 The Female Health Company Main Business Overview
13.9.5 The Female Health Company Latest Developments
13.10 Abviee Inc
13.10.1 Abviee Inc Company Information
13.10.2 Abviee Inc Contraceptive Transdermal Patche Product Portfolios and Specifications
13.10.3 Abviee Inc Contraceptive Transdermal Patche Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Abviee Inc Main Business Overview
13.10.5 Abviee Inc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Contraceptive Transdermal Patche Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Contraceptive Transdermal Patche Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Progestin-only Contraceptive
Table 4. Major Players of Combined Hormonal Contraceptive
Table 5. Global Contraceptive Transdermal Patche Sales by Type (2020-2025) & (K Units)
Table 6. Global Contraceptive Transdermal Patche Sales Market Share by Type (2020-2025)
Table 7. Global Contraceptive Transdermal Patche Revenue by Type (2020-2025) & ($ million)
Table 8. Global Contraceptive Transdermal Patche Revenue Market Share by Type (2020-2025)
Table 9. Global Contraceptive Transdermal Patche Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global Contraceptive Transdermal Patche Sale by Application (2020-2025) & (K Units)
Table 11. Global Contraceptive Transdermal Patche Sale Market Share by Application (2020-2025)
Table 12. Global Contraceptive Transdermal Patche Revenue by Application (2020-2025) & ($ million)
Table 13. Global Contraceptive Transdermal Patche Revenue Market Share by Application (2020-2025)
Table 14. Global Contraceptive Transdermal Patche Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Contraceptive Transdermal Patche Sales by Company (2020-2025) & (K Units)
Table 16. Global Contraceptive Transdermal Patche Sales Market Share by Company (2020-2025)
Table 17. Global Contraceptive Transdermal Patche Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Contraceptive Transdermal Patche Revenue Market Share by Company (2020-2025)
Table 19. Global Contraceptive Transdermal Patche Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Contraceptive Transdermal Patche Producing Area Distribution and Sales Area
Table 21. Players Contraceptive Transdermal Patche Products Offered
Table 22. Contraceptive Transdermal Patche Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Contraceptive Transdermal Patche Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Contraceptive Transdermal Patche Sales Market Share Geographic Region (2020-2025)
Table 27. Global Contraceptive Transdermal Patche Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Contraceptive Transdermal Patche Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Contraceptive Transdermal Patche Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Contraceptive Transdermal Patche Sales Market Share by Country/Region (2020-2025)
Table 31. Global Contraceptive Transdermal Patche Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Contraceptive Transdermal Patche Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Contraceptive Transdermal Patche Sales by Country (2020-2025) & (K Units)
Table 34. Americas Contraceptive Transdermal Patche Sales Market Share by Country (2020-2025)
Table 35. Americas Contraceptive Transdermal Patche Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Contraceptive Transdermal Patche Sales by Type (2020-2025) & (K Units)
Table 37. Americas Contraceptive Transdermal Patche Sales by Application (2020-2025) & (K Units)
Table 38. APAC Contraceptive Transdermal Patche Sales by Region (2020-2025) & (K Units)
Table 39. APAC Contraceptive Transdermal Patche Sales Market Share by Region (2020-2025)
Table 40. APAC Contraceptive Transdermal Patche Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Contraceptive Transdermal Patche Sales by Type (2020-2025) & (K Units)
Table 42. APAC Contraceptive Transdermal Patche Sales by Application (2020-2025) & (K Units)
Table 43. Europe Contraceptive Transdermal Patche Sales by Country (2020-2025) & (K Units)
Table 44. Europe Contraceptive Transdermal Patche Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Contraceptive Transdermal Patche Sales by Type (2020-2025) & (K Units)
Table 46. Europe Contraceptive Transdermal Patche Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Contraceptive Transdermal Patche Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Contraceptive Transdermal Patche Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Contraceptive Transdermal Patche Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Contraceptive Transdermal Patche Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Contraceptive Transdermal Patche
Table 52. Key Market Challenges & Risks of Contraceptive Transdermal Patche
Table 53. Key Industry Trends of Contraceptive Transdermal Patche
Table 54. Contraceptive Transdermal Patche Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Contraceptive Transdermal Patche Distributors List
Table 57. Contraceptive Transdermal Patche Customer List
Table 58. Global Contraceptive Transdermal Patche Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Contraceptive Transdermal Patche Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Contraceptive Transdermal Patche Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Contraceptive Transdermal Patche Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Contraceptive Transdermal Patche Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Contraceptive Transdermal Patche Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Contraceptive Transdermal Patche Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Contraceptive Transdermal Patche Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Contraceptive Transdermal Patche Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Contraceptive Transdermal Patche Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Contraceptive Transdermal Patche Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Contraceptive Transdermal Patche Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Contraceptive Transdermal Patche Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Contraceptive Transdermal Patche Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Mylan Nv Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 73. Mylan Nv Contraceptive Transdermal Patche Product Portfolios and Specifications
Table 74. Mylan Nv Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Mylan Nv Main Business
Table 76. Mylan Nv Latest Developments
Table 77. Ansell Limited Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 78. Ansell Limited Contraceptive Transdermal Patche Product Portfolios and Specifications
Table 79. Ansell Limited Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Ansell Limited Main Business
Table 81. Ansell Limited Latest Developments
Table 82. Bayer AG Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 83. Bayer AG Contraceptive Transdermal Patche Product Portfolios and Specifications
Table 84. Bayer AG Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Bayer AG Main Business
Table 86. Bayer AG Latest Developments
Table 87. Church & Dwight Co., Inc. Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 88. Church & Dwight Co., Inc. Contraceptive Transdermal Patche Product Portfolios and Specifications
Table 89. Church & Dwight Co., Inc. Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Church & Dwight Co., Inc. Main Business
Table 91. Church & Dwight Co., Inc. Latest Developments
Table 92. Merck & Co., Inc. Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 93. Merck & Co., Inc. Contraceptive Transdermal Patche Product Portfolios and Specifications
Table 94. Merck & Co., Inc. Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Merck & Co., Inc. Main Business
Table 96. Merck & Co., Inc. Latest Developments
Table 97. Pfizer Inc. Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 98. Pfizer Inc. Contraceptive Transdermal Patche Product Portfolios and Specifications
Table 99. Pfizer Inc. Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Pfizer Inc. Main Business
Table 101. Pfizer Inc. Latest Developments
Table 102. Teva Pharmaceutical Industries Limited Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 103. Teva Pharmaceutical Industries Limited Contraceptive Transdermal Patche Product Portfolios and Specifications
Table 104. Teva Pharmaceutical Industries Limited Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Teva Pharmaceutical Industries Limited Main Business
Table 106. Teva Pharmaceutical Industries Limited Latest Developments
Table 107. The Cooper Companies, Inc. Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 108. The Cooper Companies, Inc. Contraceptive Transdermal Patche Product Portfolios and Specifications
Table 109. The Cooper Companies, Inc. Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. The Cooper Companies, Inc. Main Business
Table 111. The Cooper Companies, Inc. Latest Developments
Table 112. The Female Health Company Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 113. The Female Health Company Contraceptive Transdermal Patche Product Portfolios and Specifications
Table 114. The Female Health Company Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. The Female Health Company Main Business
Table 116. The Female Health Company Latest Developments
Table 117. Abviee Inc Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 118. Abviee Inc Contraceptive Transdermal Patche Product Portfolios and Specifications
Table 119. Abviee Inc Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Abviee Inc Main Business
Table 121. Abviee Inc Latest Developments
Table 1. Contraceptive Transdermal Patche Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Contraceptive Transdermal Patche Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Progestin-only Contraceptive
Table 4. Major Players of Combined Hormonal Contraceptive
Table 5. Global Contraceptive Transdermal Patche Sales by Type (2020-2025) & (K Units)
Table 6. Global Contraceptive Transdermal Patche Sales Market Share by Type (2020-2025)
Table 7. Global Contraceptive Transdermal Patche Revenue by Type (2020-2025) & ($ million)
Table 8. Global Contraceptive Transdermal Patche Revenue Market Share by Type (2020-2025)
Table 9. Global Contraceptive Transdermal Patche Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global Contraceptive Transdermal Patche Sale by Application (2020-2025) & (K Units)
Table 11. Global Contraceptive Transdermal Patche Sale Market Share by Application (2020-2025)
Table 12. Global Contraceptive Transdermal Patche Revenue by Application (2020-2025) & ($ million)
Table 13. Global Contraceptive Transdermal Patche Revenue Market Share by Application (2020-2025)
Table 14. Global Contraceptive Transdermal Patche Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Contraceptive Transdermal Patche Sales by Company (2020-2025) & (K Units)
Table 16. Global Contraceptive Transdermal Patche Sales Market Share by Company (2020-2025)
Table 17. Global Contraceptive Transdermal Patche Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Contraceptive Transdermal Patche Revenue Market Share by Company (2020-2025)
Table 19. Global Contraceptive Transdermal Patche Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Contraceptive Transdermal Patche Producing Area Distribution and Sales Area
Table 21. Players Contraceptive Transdermal Patche Products Offered
Table 22. Contraceptive Transdermal Patche Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Contraceptive Transdermal Patche Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Contraceptive Transdermal Patche Sales Market Share Geographic Region (2020-2025)
Table 27. Global Contraceptive Transdermal Patche Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Contraceptive Transdermal Patche Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Contraceptive Transdermal Patche Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Contraceptive Transdermal Patche Sales Market Share by Country/Region (2020-2025)
Table 31. Global Contraceptive Transdermal Patche Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Contraceptive Transdermal Patche Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Contraceptive Transdermal Patche Sales by Country (2020-2025) & (K Units)
Table 34. Americas Contraceptive Transdermal Patche Sales Market Share by Country (2020-2025)
Table 35. Americas Contraceptive Transdermal Patche Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Contraceptive Transdermal Patche Sales by Type (2020-2025) & (K Units)
Table 37. Americas Contraceptive Transdermal Patche Sales by Application (2020-2025) & (K Units)
Table 38. APAC Contraceptive Transdermal Patche Sales by Region (2020-2025) & (K Units)
Table 39. APAC Contraceptive Transdermal Patche Sales Market Share by Region (2020-2025)
Table 40. APAC Contraceptive Transdermal Patche Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Contraceptive Transdermal Patche Sales by Type (2020-2025) & (K Units)
Table 42. APAC Contraceptive Transdermal Patche Sales by Application (2020-2025) & (K Units)
Table 43. Europe Contraceptive Transdermal Patche Sales by Country (2020-2025) & (K Units)
Table 44. Europe Contraceptive Transdermal Patche Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Contraceptive Transdermal Patche Sales by Type (2020-2025) & (K Units)
Table 46. Europe Contraceptive Transdermal Patche Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Contraceptive Transdermal Patche Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Contraceptive Transdermal Patche Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Contraceptive Transdermal Patche Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Contraceptive Transdermal Patche Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Contraceptive Transdermal Patche
Table 52. Key Market Challenges & Risks of Contraceptive Transdermal Patche
Table 53. Key Industry Trends of Contraceptive Transdermal Patche
Table 54. Contraceptive Transdermal Patche Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Contraceptive Transdermal Patche Distributors List
Table 57. Contraceptive Transdermal Patche Customer List
Table 58. Global Contraceptive Transdermal Patche Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Contraceptive Transdermal Patche Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Contraceptive Transdermal Patche Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Contraceptive Transdermal Patche Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Contraceptive Transdermal Patche Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Contraceptive Transdermal Patche Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Contraceptive Transdermal Patche Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Contraceptive Transdermal Patche Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Contraceptive Transdermal Patche Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Contraceptive Transdermal Patche Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Contraceptive Transdermal Patche Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Contraceptive Transdermal Patche Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Contraceptive Transdermal Patche Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Contraceptive Transdermal Patche Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Mylan Nv Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 73. Mylan Nv Contraceptive Transdermal Patche Product Portfolios and Specifications
Table 74. Mylan Nv Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Mylan Nv Main Business
Table 76. Mylan Nv Latest Developments
Table 77. Ansell Limited Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 78. Ansell Limited Contraceptive Transdermal Patche Product Portfolios and Specifications
Table 79. Ansell Limited Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Ansell Limited Main Business
Table 81. Ansell Limited Latest Developments
Table 82. Bayer AG Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 83. Bayer AG Contraceptive Transdermal Patche Product Portfolios and Specifications
Table 84. Bayer AG Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Bayer AG Main Business
Table 86. Bayer AG Latest Developments
Table 87. Church & Dwight Co., Inc. Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 88. Church & Dwight Co., Inc. Contraceptive Transdermal Patche Product Portfolios and Specifications
Table 89. Church & Dwight Co., Inc. Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Church & Dwight Co., Inc. Main Business
Table 91. Church & Dwight Co., Inc. Latest Developments
Table 92. Merck & Co., Inc. Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 93. Merck & Co., Inc. Contraceptive Transdermal Patche Product Portfolios and Specifications
Table 94. Merck & Co., Inc. Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Merck & Co., Inc. Main Business
Table 96. Merck & Co., Inc. Latest Developments
Table 97. Pfizer Inc. Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 98. Pfizer Inc. Contraceptive Transdermal Patche Product Portfolios and Specifications
Table 99. Pfizer Inc. Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Pfizer Inc. Main Business
Table 101. Pfizer Inc. Latest Developments
Table 102. Teva Pharmaceutical Industries Limited Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 103. Teva Pharmaceutical Industries Limited Contraceptive Transdermal Patche Product Portfolios and Specifications
Table 104. Teva Pharmaceutical Industries Limited Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Teva Pharmaceutical Industries Limited Main Business
Table 106. Teva Pharmaceutical Industries Limited Latest Developments
Table 107. The Cooper Companies, Inc. Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 108. The Cooper Companies, Inc. Contraceptive Transdermal Patche Product Portfolios and Specifications
Table 109. The Cooper Companies, Inc. Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. The Cooper Companies, Inc. Main Business
Table 111. The Cooper Companies, Inc. Latest Developments
Table 112. The Female Health Company Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 113. The Female Health Company Contraceptive Transdermal Patche Product Portfolios and Specifications
Table 114. The Female Health Company Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. The Female Health Company Main Business
Table 116. The Female Health Company Latest Developments
Table 117. Abviee Inc Basic Information, Contraceptive Transdermal Patche Manufacturing Base, Sales Area and Its Competitors
Table 118. Abviee Inc Contraceptive Transdermal Patche Product Portfolios and Specifications
Table 119. Abviee Inc Contraceptive Transdermal Patche Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Abviee Inc Main Business
Table 121. Abviee Inc Latest Developments
LIST OF FIGURES
Figure 1. Picture of Contraceptive Transdermal Patche
Figure 2. Contraceptive Transdermal Patche Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Contraceptive Transdermal Patche Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Contraceptive Transdermal Patche Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Contraceptive Transdermal Patche Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Contraceptive Transdermal Patche Sales Market Share by Country/Region (2024)
Figure 10. Contraceptive Transdermal Patche Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Progestin-only Contraceptive
Figure 12. Product Picture of Combined Hormonal Contraceptive
Figure 13. Global Contraceptive Transdermal Patche Sales Market Share by Type in 2025
Figure 14. Global Contraceptive Transdermal Patche Revenue Market Share by Type (2020-2025)
Figure 15. Contraceptive Transdermal Patche Consumed in Hospitals
Figure 16. Global Contraceptive Transdermal Patche Market: Hospitals (2020-2025) & (K Units)
Figure 17. Contraceptive Transdermal Patche Consumed in Household
Figure 18. Global Contraceptive Transdermal Patche Market: Household (2020-2025) & (K Units)
Figure 19. Contraceptive Transdermal Patche Consumed in Clinics
Figure 20. Global Contraceptive Transdermal Patche Market: Clinics (2020-2025) & (K Units)
Figure 21. Global Contraceptive Transdermal Patche Sale Market Share by Application (2024)
Figure 22. Global Contraceptive Transdermal Patche Revenue Market Share by Application in 2025
Figure 23. Contraceptive Transdermal Patche Sales by Company in 2025 (K Units)
Figure 24. Global Contraceptive Transdermal Patche Sales Market Share by Company in 2025
Figure 25. Contraceptive Transdermal Patche Revenue by Company in 2025 ($ millions)
Figure 26. Global Contraceptive Transdermal Patche Revenue Market Share by Company in 2025
Figure 27. Global Contraceptive Transdermal Patche Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Contraceptive Transdermal Patche Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Contraceptive Transdermal Patche Sales 2020-2025 (K Units)
Figure 30. Americas Contraceptive Transdermal Patche Revenue 2020-2025 ($ millions)
Figure 31. APAC Contraceptive Transdermal Patche Sales 2020-2025 (K Units)
Figure 32. APAC Contraceptive Transdermal Patche Revenue 2020-2025 ($ millions)
Figure 33. Europe Contraceptive Transdermal Patche Sales 2020-2025 (K Units)
Figure 34. Europe Contraceptive Transdermal Patche Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Contraceptive Transdermal Patche Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Contraceptive Transdermal Patche Revenue 2020-2025 ($ millions)
Figure 37. Americas Contraceptive Transdermal Patche Sales Market Share by Country in 2025
Figure 38. Americas Contraceptive Transdermal Patche Revenue Market Share by Country (2020-2025)
Figure 39. Americas Contraceptive Transdermal Patche Sales Market Share by Type (2020-2025)
Figure 40. Americas Contraceptive Transdermal Patche Sales Market Share by Application (2020-2025)
Figure 41. United States Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Contraceptive Transdermal Patche Sales Market Share by Region in 2025
Figure 46. APAC Contraceptive Transdermal Patche Revenue Market Share by Region (2020-2025)
Figure 47. APAC Contraceptive Transdermal Patche Sales Market Share by Type (2020-2025)
Figure 48. APAC Contraceptive Transdermal Patche Sales Market Share by Application (2020-2025)
Figure 49. China Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 53. India Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Contraceptive Transdermal Patche Sales Market Share by Country in 2025
Figure 57. Europe Contraceptive Transdermal Patche Revenue Market Share by Country (2020-2025)
Figure 58. Europe Contraceptive Transdermal Patche Sales Market Share by Type (2020-2025)
Figure 59. Europe Contraceptive Transdermal Patche Sales Market Share by Application (2020-2025)
Figure 60. Germany Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 61. France Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Contraceptive Transdermal Patche Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Contraceptive Transdermal Patche Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Contraceptive Transdermal Patche Sales Market Share by Application (2020-2025)
Figure 68. Egypt Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Contraceptive Transdermal Patche in 2025
Figure 74. Manufacturing Process Analysis of Contraceptive Transdermal Patche
Figure 75. Industry Chain Structure of Contraceptive Transdermal Patche
Figure 76. Channels of Distribution
Figure 77. Global Contraceptive Transdermal Patche Sales Market Forecast by Region (2026-2031)
Figure 78. Global Contraceptive Transdermal Patche Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Contraceptive Transdermal Patche Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Contraceptive Transdermal Patche Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Contraceptive Transdermal Patche Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Contraceptive Transdermal Patche Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Contraceptive Transdermal Patche
Figure 2. Contraceptive Transdermal Patche Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Contraceptive Transdermal Patche Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Contraceptive Transdermal Patche Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Contraceptive Transdermal Patche Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Contraceptive Transdermal Patche Sales Market Share by Country/Region (2024)
Figure 10. Contraceptive Transdermal Patche Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Progestin-only Contraceptive
Figure 12. Product Picture of Combined Hormonal Contraceptive
Figure 13. Global Contraceptive Transdermal Patche Sales Market Share by Type in 2025
Figure 14. Global Contraceptive Transdermal Patche Revenue Market Share by Type (2020-2025)
Figure 15. Contraceptive Transdermal Patche Consumed in Hospitals
Figure 16. Global Contraceptive Transdermal Patche Market: Hospitals (2020-2025) & (K Units)
Figure 17. Contraceptive Transdermal Patche Consumed in Household
Figure 18. Global Contraceptive Transdermal Patche Market: Household (2020-2025) & (K Units)
Figure 19. Contraceptive Transdermal Patche Consumed in Clinics
Figure 20. Global Contraceptive Transdermal Patche Market: Clinics (2020-2025) & (K Units)
Figure 21. Global Contraceptive Transdermal Patche Sale Market Share by Application (2024)
Figure 22. Global Contraceptive Transdermal Patche Revenue Market Share by Application in 2025
Figure 23. Contraceptive Transdermal Patche Sales by Company in 2025 (K Units)
Figure 24. Global Contraceptive Transdermal Patche Sales Market Share by Company in 2025
Figure 25. Contraceptive Transdermal Patche Revenue by Company in 2025 ($ millions)
Figure 26. Global Contraceptive Transdermal Patche Revenue Market Share by Company in 2025
Figure 27. Global Contraceptive Transdermal Patche Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Contraceptive Transdermal Patche Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Contraceptive Transdermal Patche Sales 2020-2025 (K Units)
Figure 30. Americas Contraceptive Transdermal Patche Revenue 2020-2025 ($ millions)
Figure 31. APAC Contraceptive Transdermal Patche Sales 2020-2025 (K Units)
Figure 32. APAC Contraceptive Transdermal Patche Revenue 2020-2025 ($ millions)
Figure 33. Europe Contraceptive Transdermal Patche Sales 2020-2025 (K Units)
Figure 34. Europe Contraceptive Transdermal Patche Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Contraceptive Transdermal Patche Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Contraceptive Transdermal Patche Revenue 2020-2025 ($ millions)
Figure 37. Americas Contraceptive Transdermal Patche Sales Market Share by Country in 2025
Figure 38. Americas Contraceptive Transdermal Patche Revenue Market Share by Country (2020-2025)
Figure 39. Americas Contraceptive Transdermal Patche Sales Market Share by Type (2020-2025)
Figure 40. Americas Contraceptive Transdermal Patche Sales Market Share by Application (2020-2025)
Figure 41. United States Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Contraceptive Transdermal Patche Sales Market Share by Region in 2025
Figure 46. APAC Contraceptive Transdermal Patche Revenue Market Share by Region (2020-2025)
Figure 47. APAC Contraceptive Transdermal Patche Sales Market Share by Type (2020-2025)
Figure 48. APAC Contraceptive Transdermal Patche Sales Market Share by Application (2020-2025)
Figure 49. China Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 53. India Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Contraceptive Transdermal Patche Sales Market Share by Country in 2025
Figure 57. Europe Contraceptive Transdermal Patche Revenue Market Share by Country (2020-2025)
Figure 58. Europe Contraceptive Transdermal Patche Sales Market Share by Type (2020-2025)
Figure 59. Europe Contraceptive Transdermal Patche Sales Market Share by Application (2020-2025)
Figure 60. Germany Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 61. France Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Contraceptive Transdermal Patche Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Contraceptive Transdermal Patche Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Contraceptive Transdermal Patche Sales Market Share by Application (2020-2025)
Figure 68. Egypt Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Contraceptive Transdermal Patche Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Contraceptive Transdermal Patche in 2025
Figure 74. Manufacturing Process Analysis of Contraceptive Transdermal Patche
Figure 75. Industry Chain Structure of Contraceptive Transdermal Patche
Figure 76. Channels of Distribution
Figure 77. Global Contraceptive Transdermal Patche Sales Market Forecast by Region (2026-2031)
Figure 78. Global Contraceptive Transdermal Patche Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Contraceptive Transdermal Patche Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Contraceptive Transdermal Patche Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Contraceptive Transdermal Patche Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Contraceptive Transdermal Patche Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Automatic Opening Laparoscopic Retrieval Bag Market Growth 2024-2030
US$ 3,660.00
March 2024
116 pages
Global Metabolic Testing Solutions Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
September 2024
116 pages
Global Community Oncology Service Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
March 2023
86 pages
Global Pipettes Market Growth 2024-2030
US$ 3,660.00
December 2024
160 pages
Global Single-Patient Stethoscopes Market Growth 2024-2030
US$ 3,660.00
August 2024
107 pages
